Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Savara Inc. | 1 | 0 | 0 | 0 | €4.62 | €8.00 | 73.160% |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.80 | - | - |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Knight Therapeutics | 1 | 0 | 0 | 0 | €4.00 | €10.00 | 150.000% |
| Poxel S.A. | 1 | 0 | 0 | 0 | €0.62 | €0.70 | 12.179% |
| Enlivex Therapeutics Ltd. | 1 | 0 | 1 | 0 | €1.43 | - | - |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €83.65 | €100.00 | 19.546% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €39.40 | €50.00 | 26.904% |
| Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.68 | €4.00 | 49.254% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.44 | €4.00 | 63.934% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.75 | - | - |
| Novavax Inc. | 4 | 3 | 2 | 1 | €8.26 | €82.00 | 893.097% |
| GSK plc | 1 | 0 | 0 | 0 | €20.87 | - | - |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.48 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €120.00 | €109.00 | -9.167% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.28 | - | - |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.80 | - | - |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.080 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €352.00 | - | - |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €124.00 | €150.00 | 20.968% |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.50 | - | - |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €25.00 | - | - |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.54 | €6.00 | 69.731% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.45 | €130.00 | 6.166% |